(Q49531210)

21 February 2018

title

Benactyzine in psychoneurosis, with a note on the E.E.G. changes in normal subjects. (English)

1 reference

21 February 2018

1 reference

RAYMOND MJ

1

1 reference

21 February 2018

LUCAS CJ

series ordinal

2

1 reference

21 February 2018

language of work or name

English

0 references

publication date

1 April 1956

1 reference

21 February 2018

published in

The BMJ

1 reference

21 February 2018

volume

1

1 reference

21 February 2018

issue

4973

1 reference

21 February 2018

page(s)

952-954

1 reference

21 February 2018

Treatment of psychoses and psychoneuroses with a new sedative (suavitil).

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1979798

A clinical trial of benactyzine hydrochloride (suavitil) as a physical relaxant.

14 August 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1979798

Suavitil in the treatment of psychoneuroses

14 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/13304390

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Suavitil, a new compound with specific effect on the central nervous system]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/13304390

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.1.4973.952

1 reference

21 February 2018

PMC publication ID

1979798

1 reference

21 February 2018

PubMed publication ID

13304390

1 reference

21 February 2018